摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

7,8-二氯-苯并[g]蝶啶-2,4(1H,3H)-二酮 | 58590-56-0

中文名称
7,8-二氯-苯并[g]蝶啶-2,4(1H,3H)-二酮
中文别名
——
英文名称
7,8-dichloroalloxazine
英文别名
dichloroalloxazine;7,8-dichloro-1H-benzo[g]pteridine-2,4-dione;7,8-Dichlor-1H-benzo[g]pteridin-2,4-dion;7,8-dichloro-alloxazine;Benzo(g)pteridine-2,4(1H,3H)-dione, 7,8-dichloro-;7,8-dichloro-1H-benzo[g]pteridine-2,4-dione
7,8-二氯-苯并[g]蝶啶-2,4(1H,3H)-二酮化学式
CAS
58590-56-0
化学式
C10H4Cl2N4O2
mdl
——
分子量
283.073
InChiKey
AXUFSJZRCPNZIQ-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    1.7
  • 重原子数:
    18
  • 可旋转键数:
    0
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.0
  • 拓扑面积:
    84
  • 氢给体数:
    2
  • 氢受体数:
    4

安全信息

  • 海关编码:
    2933990090

SDS

SDS:e60404b4f4f2720d14883b91b90b1770
查看

反应信息

  • 作为反应物:
    参考文献:
    名称:
    Synthesis and oral antiallergic activity of carboxylic acids derived from imidazo[2,1-c][1,4]benzoxazines, imidazo[1,2-a]quinolines, imidazo[1,2-a]quinoxalines, imidazo[1,2-a]quinoxalinones, pyrrolo[1,2-a]quinoxalinones, pyrrolo[2,3-a]quinoxalinones, and imidazo[2,1-b]benzothiazoles
    摘要:
    4H-Imidazo[2,1-c][1,4]benzoxazine-2-carboxylic acid (3) was found to possess potent activity in the IgE-induced rat passive cutaneous anaphylaxis model which may be predictive of clinical antiallergic activity. Compared to disodium cromoglycate (DSCG, 1), 3 was less active following iv administration but unlike DSCG showed very significant oral activity. To explore the structural requirements for this activity, a range of tricyclic compounds was prepared and their activities were measured. Individual 2-carboxylic acids derived from imidazo[1,2-a]quinolines, imidazo[1,2-a]quinoxalines, imidazo[1,2-a]quinoxalinones, pyrrolo[1,2-a]quinoxalinones, pyrrolo[2,3-a]quinoxalinones, and imidazo[2,1-b]benzothiazoles showed iv activities up to 10(3) times as potent as DSCG and many of them showed significant oral activity. From these, imidazo[1,2-a]quinoxaline-2-carboxylic acid 114 has been chosen for further development.
    DOI:
    10.1021/jm00401a009
  • 作为产物:
    描述:
    4,5-二氯邻苯二胺四氧嘧啶硼酸 作用下, 以 溶剂黄146 为溶剂, 以85%的产率得到7,8-二氯-苯并[g]蝶啶-2,4(1H,3H)-二酮
    参考文献:
    名称:
    Synthesis and oral antiallergic activity of carboxylic acids derived from imidazo[2,1-c][1,4]benzoxazines, imidazo[1,2-a]quinolines, imidazo[1,2-a]quinoxalines, imidazo[1,2-a]quinoxalinones, pyrrolo[1,2-a]quinoxalinones, pyrrolo[2,3-a]quinoxalinones, and imidazo[2,1-b]benzothiazoles
    摘要:
    4H-Imidazo[2,1-c][1,4]benzoxazine-2-carboxylic acid (3) was found to possess potent activity in the IgE-induced rat passive cutaneous anaphylaxis model which may be predictive of clinical antiallergic activity. Compared to disodium cromoglycate (DSCG, 1), 3 was less active following iv administration but unlike DSCG showed very significant oral activity. To explore the structural requirements for this activity, a range of tricyclic compounds was prepared and their activities were measured. Individual 2-carboxylic acids derived from imidazo[1,2-a]quinolines, imidazo[1,2-a]quinoxalines, imidazo[1,2-a]quinoxalinones, pyrrolo[1,2-a]quinoxalinones, pyrrolo[2,3-a]quinoxalinones, and imidazo[2,1-b]benzothiazoles showed iv activities up to 10(3) times as potent as DSCG and many of them showed significant oral activity. From these, imidazo[1,2-a]quinoxaline-2-carboxylic acid 114 has been chosen for further development.
    DOI:
    10.1021/jm00401a009
点击查看最新优质反应信息

文献信息

  • Novel imidazoquinoxalines
    申请人:Roussel Uclaf
    公开号:US04254123A1
    公开(公告)日:1981-03-03
    Novel imidazoquinoxalines of the formula ##STR1## wherein R is selected from the group consisting of hydrogen, alkyl of 1 to 5 carbon atoms, --NH.sub.4, alkali metal, alkaline earth metal, magnesium, aluminum and non-toxic, pharmaceutically acceptable amines, X is selected from the group consisting of hydrogen, alkoxy of 1 to 5 carbon atoms and carbamoyl and Y and Z are individually selected from the group consisting of hydrogen and halogen and their non-toxic, pharmaceutically acceptable acid addition salts having anti-allergic activity and their preparation.
    该专利描述了一种公式为##STR1##的新型咪唑喹啉类化合物,其中R选自氢、1至5个碳原子的烷基、--NH.sub.4、碱属、碱土属、、铝和非毒性、药学上可接受的胺类;X选自氢、1至5个碳原子的烷氧基和基甲酰基;Y和Z各自选自氢和卤素,以及它们的非毒性、药学上可接受的酸盐,具有抗过敏活性。该专利还涉及了这些化合物的制备方法。
  • A triangular prismatic hexanuclear iridium(<scp>iii</scp>) complex bridged by flavin analogues showing reversible redox processes
    作者:Yuji Inui、Motoo Shiro、Takahiro Kusukawa、Shunichi Fukuzumi、Takahiko Kojima
    DOI:10.1039/c2dt32535g
    日期:——
    spectroscopic and electrochemical measurements. The alloxazine ligands showed unprecedented coordination modes to link the six Ir(III) centres. The complex exhibited remarkable stability and reversible six-electron redox processes at the bridging alloxazine ligands in organic solvents. The first reversible reduction process occurred on each of three alloxazine ligands in 1 to produce a three-electron-reduced
    物[Ir 6(μ-alloCl 2 2-)3(CP *)6(OH)3 ](PF 6)3(1),其具有7,8-二价阴离子dichloroalloxazine(alloCl 2 2-)作为桥连配体的合成和表征通过X射线晶体学,光谱学和电化学测量。别恶嗪配体显示出前所未有的配位模式来连接六个Ir(III)中心。该络合物在有机溶剂中桥联四恶嗪配体上显示出显着的稳定性和可逆的六电子氧化还原过程。第一个可逆的还原过程发生在1中的三个Alloxazine配体上以产生三电子还原的物种,物[Ir III 6的CP * 6(μ-alloCl 2 ˙ 3-)3(OH)3 ],并观察作为表观一步还原过程在-0.65 V(VS Fc 0 / +)。在几乎相同的电位-0.78 V(vs . Fc 0 / +)下,记录了1中的三个Alloxazine配体的第二个可逆还原过程,得到六电子还原形式[Ir III 6 CP *
  • Organocatalytic Dakin Oxidation by Nucleophilic Flavin Catalysts
    作者:Shuai Chen、Mohammad S. Hossain、Frank W. Foss
    DOI:10.1021/ol3010326
    日期:2012.6.1
    Flavin catalysts perform the first organocatalytic Dakin oxidation of electron-rich arylaldehydes to phenols under mild, basic conditions. Catechols are readily prepared, and the oxidation of 2-hydroxyacetophenone was achieved. Aerobic oxidation is displayed in the presence of Zn(0) as a reducing agent. This reactivity broadens the scope of biomimetic flavin catalysis in the realm of nucleophilic oxidations, providing a framework for mechanistic investigations for related oxidations, such as the Baeyer-Villiger oxidation and Weitz-Scheffer epoxidation.
  • Electron-Deficient Alloxazinium Salts: Efficient Organocatalysts of Mild and Chemoselective Sulfoxidations with Hydrogen Peroxide
    作者:Petra Ménová、Hana Dvořáková、Václav Eigner、Jiří Ludvík、Radek Cibulka
    DOI:10.1002/adsc.201300617
    日期:2013.11.25
    AbstractA series of substituted alloxazinium perchlorates has been prepared and tested as catalysts for the oxidation of sulfides to sulfoxides with hydrogen peroxide. The logarithms of the observed rate constants of thioanisole oxidation correlate with the Hammett σ constants of the substituents on the alloxazinium catalysts, as well as with their reduction potentials E0′ and their pKR+ values, representing the alloxazinium salt/pseudobase equilibrium. The stronger the electron‐withdrawing substituent, the more efficient is the alloxazinium catalyst. The alloxazinium salts with a cyano or trifluoromethyl group in position 8 proved to be the most efficient, operating at room temperature at small loadings, down to 0.1 mol%, achieving turnover number values of up to 640 and acceleration by a factor of 350 relative to the non‐catalyzed oxidation. The 8‐cyanoalloxazinium perchlorate was evaluated as the best catalyst; however, due to its relatively good accessibility, the 8‐(trifluoromethyl)alloxazinium perchlorate seems to be the catalyst of choice for sulfoxidations with hydrogen peroxide. It was successfully tested for the sulfoxidation of a series of aliphatic and aromatic sulfides on a preparative scale. It produced the corresponding sulfoxides in quantitative conversions and with high isolated yields (87–98%). No over‐oxidation to sulfone was ever observed.magnified image
  • 144. A series of 9-dialkylaminoalkylisoalloxazines
    作者:R. B. Barlow、H. R. Ing
    DOI:10.1039/jr9500000713
    日期:——
查看更多

同类化合物

黄素酰色氨酸 高蝶酸 骏河毒素 酵母粉 诺米林酸17-β-D-吡喃葡萄糖苷 蝶酸 蝶啶3-氧化物 蝶啶-6-基-甲醇 蝶啶-4,6-二胺 蝶啶-2,4-二胺 蝶呤-6-羧酸 苯癸酸,2-羟基-3,4-二甲氧基-6-甲基 苯并[g]蝶啶-4a(2H)-基,5-乙基-3,4,5,10-四氢-3,7,8,10-四甲基-2,4-二羰基- 苯并[g]蝶啶-2,4(1H,3H)-二酮,5-乙酰基-5,10-二氢-1,3-二甲基- 苯并[g]蝶啶-2,4(1H,3H)-二酮,5,10-二氢-7,8-二甲基- 苯并[g]蝶啶-2,4(1H,3H)-二酮,1,7,8-三甲基- 羧甲基黄素 羟基-2-吡啶酮 维生素 B2 维他命 B2 硫酸氢3-(6,7-二氯-2,4-二羰基-3,4-二氢苯并[g]蝶啶-10(2H)-基)-N-乙基-N-(2-羟基乙基)丙烷-1-铵 硫酸氢2-(7,8-二氯-2,4-二羰基-3,4-二氢苯并[g]蝶啶-10(2H)-基)-N,N-二甲基乙铵 甲氨蝶呤钠 甲氨蝶呤杂质1 生物蝶呤-d3 生物喋呤中间体 环己烯,3-氟-4-(甲硫基)-,反-(9CI) 玫瑰黄色素 溴化氢溴化1-(2-氨基乙基)-3-甲基-4-[(Z)-2-萘-1-基乙烯基]吡啶正离子 氯化3-(7-氯-2,4-二羰基-3,4-二氢苯并[g]蝶啶-10(2H)-基)-N,N-二甲基丙烷-1-铵 氨蝶呤钠 氨苯蝶啶 氨甲酸,[(1S)-2-羟基-1-甲基丙基]-,1,1-二甲基乙基酯(9CI) 氨甲蝶呤 氨基蝶呤 核黄素还原 核黄素杂质Q 核黄素5'-硫酸盐 核黄素3′,4′-二磷酸酯 核黄素-4'-磷酸 核黄素-3'-磷酸盐 核黄素,2',3',4',5'-四乙酸酯 核黄素 5'-丁酸酯 核黄素 无色喋呤 异黄蝶呤 己二酸,2-[[4-[[(2-氨基-1,4,5,6,7,8-六氢-4-羰基-6-蝶啶基)甲基]氨基]苯甲酰]氨基]- 左亚叶酸钙杂质 左亚叶酸钙 四氢蝶酰五谷氨酸酯